Exhaled nitric oxide levels in atopic children: relation specific allergic sensitisation, AHR, and respiratory symptoms

Leuppi, J. D.; Downs, S. H.; Downie, S. R.; Marks, G. B.; Salome, C. M.
June 2002
Thorax;Jun2002, Vol. 57 Issue 6, p518
Academic Journal
Background: Exhaled nitric oxide (eNO), which has been proposed as a measure of airway inflammation, is increased in atopic subjects. This raises the question of whether eNO provides any additional information about airway inflammation in asthmatic subjects, other than as a marker for atopy. A study was undertaken to determine whether eNO levels in a population of atopic children are associated with sensitisation or natural exposure to specific allergens, and to examine the relationship between eNO, airway responsiveness, and current respiratory symptoms. Methods: Exhaled NO and airway responsiveness to histamine were measured in winter and in sum mer in 235 children aged 8-14 years who had been classified as atopic by skin prick testing. Curren respiratory symptoms, defined as wheeze or cough during the month preceding the test, were measured by a parent completed questionnaire. Airway hyperresponsiveness (AHR) was defined as a dose response ratio (DRR) of >8.1 (% fall in forced expiratory volume in 1 second (FEV1/μmol + 3). Results: Sensitisation to house dust mite was associated with raised eNO levels in winter while sensitisation to Cladosporium was associated with raised eNO levels in both winter and summer. Grass pollen sensitisation was not associated with raised eNO levels in either season. Exhaled NO correlated significantly with DRR histamine (r=0.43, p<0.001) independently of whether the children hod current symptoms or not. In children with current wheeze, those with AHR had eNO levels 1 .53 (95% Cl 1 .41 to 1.06) times higher than those without AHR (p=0.006). Neither DRR (p=1 .0) nor eNO levels (p=0.92) differed significantly between children with or without persistent dry cough in the absence of wheeze. Conclusions: In atopic children, raised eNO levels are associated with sensitisation to perennial allergens, but not to seasonal allergens such as grass pollen. In this population, an increase in eNO is associated with AHR and current wheezing, suggesting that eNO is more than lust a marker for atopy.


Related Articles

  • Eat dirt and avoid atopy: The hygiene hypothesis revisited. Patki, Anil // Indian Journal of Dermatology, Venereology & Leprology;Jan/Feb2007, Vol. 73 Issue 1, p2 

    The explosive rise in the incidence of atopic diseases in the Western developed countries can be explained on the basis of the so-called "hygiene hypothesis". In short, it attributes the rising incidence of atopic dermatitis to reduced exposure to various childhood infections and bacterial...

  • Canine Models of Atopic Dermatitis: A Useful Tool with Untapped Potential. Marsella, Rosanna; Girolomoni, Giampiero // Journal of Investigative Dermatology;Oct2009, Vol. 129 Issue 10, p2351 

    Animal models have contributed greatly to the expansion of knowledge in the field of atopic dermatitis (AD). Some species, such as the dog, naturally and commonly develop a pruritic dermatitis that is clinically and immunologically extremely similar to human AD. Recently, canine models of AD...

  • Human thymic stromal lymphopoietin: a novel epithelial cell-derived cytokine and a potential key player in the induction of allergic inflammation. Soumelis, Vassili; Liu, Yong-Jun // Springer Seminars in Immunopathology;Feb2004, Vol. 25 Issue 3/4, p325 

    Allergy is the result of a complex immune cascade leading to the dysregulated production of Th2 cytokines, the generation of allergen-specific IgE-producing B cells and the subsequent activation and degranulation of mast cells upon allergen challenge. Dendritic cells (DCs) play an important role...

  • TIM-1,a novel allergy and asthma susceptibility gene. McIntire, Jennifer J.; Umetsu, Dale T.; DeKruyff, Rosemarie H. // Springer Seminars in Immunopathology;Feb2004, Vol. 25 Issue 3/4, p335 

    Atopic diseases, including asthma, allergic rhinitis, and atopic dermatitis, are caused by environmental factors in genetically predisposed individuals. Although the prevalence of these diseases has risen dramatically over the past two decades, it has been difficult to identify the underlying...

  • Epidemiology of atopic dermatitis: a review. DaVeiga, Sigrid Payne // Allergy & Asthma Proceedings;May/Jun2012, Vol. 33 Issue 3, p227 

    Atopic dermatitis (AD) is a common skin condition with significant associated social and financial burden. AD affects adults and children with worldwide prevalence rates of 1-20%. International study of epidemiology and geographic variability in prevalence of AD has been conducted in three...

  • Reakce na potraviny u dospívajících a dospÄ›lých pacientů s atopickým ekzémem. Čelakovská, J. // Czecho-Slovak Dermatology / Cesko-Slovenska Dermatologie;2013, Vol. 88 Issue 1, p10 

    In patients with atopic eczema the food adverse reactions are reported, most frequently defined as food intolerance. The evaluation of food adverse reactions in adolescent and adult patients suffering from atopic eczema was the aim of our study. We have performed the comprehensive dermatological...

  • Skin barrier function and allergic risk. Hudson, Thomas J. // Nature Genetics;Apr2006, Vol. 38 Issue 4, p399 

    A new study reports that two common loss-of-function mutations in the gene encoding filaggrin are important risk factors for atopic dermatitis, and interestingly, for asthma in association with atopic dermatitis, but not asthma in the absence of atopic dermatitis. These findings suggest the...

  • Immunotherapy in dogs with atopic dermatitis.  // Veterinary Record: Journal of the British Veterinary Association;1/21/2006, Vol. 158 Issue 3, p76 

    The article discusses the results of a study on the efficacy of the allergen-specific immunotherapy in dogs with atopic dermatitis. Mould proteases have the ability to degrade pollen antigens. Mould extracts have been keep separately from the other antigen extracts. Dogs are more responsive in...

  • Results of allergen-specific immunotherapy in 117 dogs with atopic dermatitis. Schnabl, B.; Bettenay, S. V.; Dow, K.; Mueller, R. S. // Veterinary Record: Journal of the British Veterinary Association;1/21/2006, Vol. 158 Issue 3, p81 

    The success of the treatment of 117 dogs with atopic dermatitis with allergen-specific immunotherapy for up to 48 months was assessed. An excellent response (remission with exclusive immunotherapy) was recorded in ! 8 of the dogs, a good response (more than 50 per cent reduction in medication...


Read the Article


Sign out of this library

Other Topics